ReachMD

Episodes 1-12 of 12

• • 

    

    Mimi Secor, DNP, FNP-BC, FAANP

    Peer

  • 

    

    Karen Bloch, MD, MPH, FIDSA, FACP

    Peer

  • 

    

    Jarrod W. Kile, RPh, BCPS

    Peer

  1

  

  RestartResume

  Connecting Care: A Multidisciplinary Panel Discussion on the Use of Neutralizing Monoclonal Antibodies in Ambulatory Patients With COVID-19

  Connecting Care: A Multidisciplinary Panel Discussion on the Use of Neutralizing Monoclonal Antibodies in Ambulatory Patients With COVID-19

  1.00 credits

• • 

    

    Jennifer W. Carlisle, MD

    Peer

  • 

    

    Suresh S. Ramalingam, MD

    Peer

  2

  

  RestartResume

  An Evolving Clinical Landscape in HER2+ and HER2-Mutant Metastatic NSCLC: Critical Updates for Your Practice

  An Evolving Clinical Landscape in HER2+ and HER2-Mutant Metastatic NSCLC: Critical Updates for Your Practice

  0.50 credits

• • 

    

    Jennifer Caudle, DO

    Peer

  • 

    

    Andrew D. Badley, MD, FRCP(C), FACP, FIDSA

    Peer

  • 

    

    Chad Worz, PharmD, BCGP, FASCP

    Peer

  0

  

  RestartResume

  Connecting Care: Outpatient Treatment of COVID-19 With Neutralizing Monoclonal Antibodies

  Connecting Care: Outpatient Treatment of COVID-19 With Neutralizing Monoclonal Antibodies

  0.75 credits

• • 

    

    Yohann Loriot, MD, PhD

    Peer

  • 

    

    Robert J. Motzer, MD

    Peer

  5

  

  RestartResume

  Principles and Practice Strategies for Immunotherapy in Genitourinary Malignancies

  Principles and Practice Strategies for Immunotherapy in Genitourinary Malignancies

  1.00 credits

• • 

    

    Edward Chu, MD

    Peer

  • 

    

    Michael J. Overman, MD

    Peer

  6

  

  RestartResume

  Keeping Pace in GI Cancer: Advances in Immunotherapy in MSI-H/dMMR Metastatic Colorectal Cancer

  Keeping Pace in GI Cancer: Advances in Immunotherapy in MSI-H/dMMR Metastatic Colorectal Cancer

  0.25 credits

• • 

    

    Ajay K. Gopal, MD

    Peer

  0

  

  RestartResume

  Expert Answers to Common Questions for Advancing the Standard of Care for Relapsed/Refractory Follicular Lymphoma

  Expert Answers to Common Questions for Advancing the Standard of Care for Relapsed/Refractory Follicular Lymphoma

  0.25 credits

• • 

    

    Ruben A. Mesa, MD, FACP

    Peer

  4

  

  RestartResume

  Part 2: Improving Quality of Care and Shared Decision-Making in Myelofibrosis

  Part 2: Improving Quality of Care and Shared Decision-Making in Myelofibrosis

  0.50 credits

• • 

    

    Ruben A. Mesa, MD, FACP

    Peer

  5

  

  RestartResume

  Part 1: Improving Quality of Care and Shared Decision-Making in Myelofibrosis

  Part 1: Improving Quality of Care and Shared Decision-Making in Myelofibrosis

  0.50 credits

• • 

    

    Karen Reckamp, MS, MD

    Peer

  • 

    

    Heather Wakelee, MD

    Peer

  5

  

  RestartResume

  Optimizing Patient Outcomes in Advanced NSCLC in a Rapidly Evolving Treatment Era

  Optimizing Patient Outcomes in Advanced NSCLC in a Rapidly Evolving Treatment Era

  1.00 credits

• • 

    

    Karen Reckamp, MS, MD

    Peer

  • 

    

    Heather Wakelee, MD

    Peer

  7

  

  RestartResume

  Optimizing Patient Outcomes in Advanced NSCLC in a Rapidly Evolving Treatment Era: A Video-based Patient Case Series

  Optimizing Patient Outcomes in Advanced NSCLC in a Rapidly Evolving Treatment Era: A Video-based Patient Case Series

  0.50 credits

• • 

    

    Keith S. Kaye, MD, MPH

    Peer

  • 

    

    Marin H. Kollef, MD, FACP, FCCP

    Peer

  • 

    

    Douglas N. Fish, PharmD

    Peer

  6

  

  RestartResume

  Critical Updates in Treating Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia

  Critical Updates in Treating Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia

  0.25 credits

• • 

    

    Jay L. Koyner, MD

    Peer

  • 

    

    Sandra L. Kane-Gill, PharmD, MS, FCCM, FCCP

    Peer

  • 

    

    John A. Kellum, MD, MCCM

    Peer

  12

  

  RestartResume

  Early Recognition of Acute Kidney Injury: What’s the Role of Biomarkers?

  Early Recognition of Acute Kidney Injury: What’s the Role of Biomarkers?

  0.25 credits